【浦银国际证券】FY22销售成绩优异，核心产品加速渗透目标市场.pdf

IMAX China(01970)FY22业绩会纪要-港股20230223-调研纪要

思摩尔国际(06969)FY22 业绩会纪要-港股-调研纪要

FY22 largely in-line; Gradual recovery on track

FY22 Preview： Strong execution of “3+3 Strategy”; Raise TP to HK$2.66

FY22 net margins better than expected

FY22E preview; Bumpy recovery in 2023

遥望科技(002291)FY22&1Q23业绩交流会-调研纪要

Yanlord：Resilient FY22 results and business model; maintain Buy

高等教育专题研究：FY22港股高教板块业绩回顾与展望

Hopson： weaker but much better than peers FY22